The U.S. Supreme Court on Monday declined to take up Amgen Inc's bid to rei...
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Amgen CEO on cholesterol drug price cut: 'Too many patients' were struggling to payJim Cramer sits down with Amgen Chairman and CEO Bob Bradway to hear about the company's recent price cut for one of its key drugs.
Lire la suite »
Stocks making the biggest moves after hours: Apple, Amgen, AMD and moreSee which stocks are posting big moves after the bell on January 29.
Lire la suite »
From Amgen to Gilead, drugmakers are sitting on billions of cash — and top pharma executives are hinting about big M&A to come in 2019Billion-dollar deals from drug giants Eli Lilly & Co. and Bristol-Myers Squibb could set the tone for a year full of healthcare acquisitions.
Lire la suite »
House Democrats launch drug-pricing probe into a dozen major health-care companiesAbbVie, Amgen, AstraZeneca, Celgene, Eli Lilly, Johnson & Johnson, Mallinckrodt, Novartis, Novo Nordisk, Pfizer, Sanofi and Teva Pharmaceuticals received letters seeking detailed information and documents about the companies' pricing practices.
Lire la suite »
U.S. lawmaker launches investigation into pharma drug pricingRepresentative Elijah Cummings, who chairs the House Oversight Committee, sent letters to 12 drugmakers seeking information on price increases, investment in research and development, and corporate strategies to preserve market share and pricing power, his office said in a statement. Novo Nordisk, Amgen
Lire la suite »
Biotech is breaking out. Here's what one analyst says to watch ahead of 3 key earnings reportsBiotech stocks are on a roll so far this year. With Amgen, Biogen, and Celgene all set to report earnings this week, here's what Baird biotech analyst Brian Skorney says investors should be watching.
Lire la suite »